Loading…
Loading…
JNJ · NYSE · Healthcare
Estimate fair value using the Graham Number, earnings-based model, and PEG-adjusted valuation. Three independent methods averaged together.
Market Cap
$571.68B
P/E Ratio
21.33
Forward P/E
—
EPS
$11.13
PEG Ratio
0.43
Book Value
$33.87
Dividend Yield
2.17%
Profit Margin
28.46%
ROE
32.87%
Use the interactive fair value with pre-loaded data for Johnson & Johnson. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for JNJ: